Motallebirad Tahereh, Tashakor Amirhossein, Abniki Reza, Azadi Davood
Department of Research and Development, Satras Biotechnology Company, Islamic Azad University of Khomein, Khomein, Iran.
Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Diagn Microbiol Infect Dis. 2024 Jan;108(1):116080. doi: 10.1016/j.diagmicrobio.2023.116080. Epub 2023 Sep 9.
Actinomycetes, ubiquitous in the natural world, have been known to inflict infections upon both immunocompromised and healthy individuals. Interestingly enough, these species are oftentimes found residing within the microbiota of humans and animals alike. Unfortunately, these infections are frequently misdiagnosed as more sinister ailments such as malignancy or tuberculosis. Due to this issue, this review deals with 15 years of study on clinical and environmental samples to determine Actinomycetes' prevalence, isolation, identification, and antibiotic susceptibility pattern in Iran by Davood Azadi et al. According to the Davood Azadi framework, we searched the following databases: PubMed/MEDLINE, Embase, Scopus, Web of Science, SID, and Google Scholar in the period from 2007 to 2023. This review aimed to provide an overview of the most recent techniques for collecting environmental samples, cultivating them, and identifying the Actinomycetes group's members. The isolation of Actinomycetes from clinical and ecological sources is becoming more prevalent and should be a concern for health authorities in developing countries. Health centers should take action to increase awareness of diagnostic criteria and management guidelines for actinomycete diseases. Improvements in national and regional reference laboratories may also aid in accurately diagnosing these diseases.
放线菌在自然界中无处不在,已知会对免疫功能低下者和健康个体造成感染。有趣的是,这些物种经常存在于人类和动物的微生物群中。不幸的是,这些感染常常被误诊为更严重的疾病,如恶性肿瘤或结核病。由于这个问题,本文献综述涉及达乌德·阿扎迪等人对伊朗临床和环境样本进行的15年研究,以确定放线菌的流行情况、分离、鉴定及抗生素敏感性模式。根据达乌德·阿扎迪的框架,我们在2007年至2023年期间搜索了以下数据库:PubMed/MEDLINE、Embase、Scopus、Web of Science、SID和谷歌学术。本文献综述旨在概述收集环境样本、培养样本以及鉴定放线菌群成员的最新技术。从临床和生态来源分离放线菌的情况越来越普遍,这应该引起发展中国家卫生当局的关注。卫生中心应采取行动,提高对放线菌病诊断标准和管理指南的认识。国家和地区参考实验室的改进也可能有助于准确诊断这些疾病。